ImmunityBio converts from Immunomedics | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
ImmunityBio converts from Immunomedics

An SI Board Since February 2023

Posts	SubjectMarks	Bans	Symbol
1518	51	0	IBRX

Emcee: TinfoilHat	Type: Moderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
510	Briefly sharing that Merck halted a Keytruda-Tigit study. Roche previously fail	TinfoilHat	7	5/13/2024
509	All good. Back on topic, scanned the 10Q and pulled these points of interest.	TinfoilHat	5	5/10/2024
508	Understood Tin. Moving on I just want to say thanks to you and others on this bo	Redman1234	-	5/10/2024
507	Hey Redman, good for you for sticking up for your internet buddy. I don't	TinfoilHat	2	5/10/2024
506	Hi Tin. This is my first time posting on this board, and yes I know that immedia	Redman1234	1	5/9/2024
505	wallstreetbetsreddit.blogspot.com	Andrew Jackson	-	5/9/2024
504	sec.gov	mannamal	-	5/9/2024
503	This End2War guy sounds like a chatbot that parrots things I have already said.	TinfoilHat	-	5/9/2024
502	I don't think that IBRX has sufficient capital for long to maintain the larg	End2War	4	5/9/2024
501	Negatives? Just dilution - if need more $$ for trials. AUPH has to get off	JJINV	1	5/8/2024
500	Absolutely concur with your thinking; IBRX is / and will be worth more than IMMU	Davidoff	4	5/8/2024
499	We are not the least bit concerned about the short interest, its size, or borrow	bobbseytwins2001	10	5/8/2024
498	Schwab has lowered their lending rate from 181/2 % to 16% which was once as high	zagnut1	-	5/8/2024
497	Also, not sure if anyone has posted this recent presentation: chrome-extension:/	End2War	-	5/7/2024
496	Patrick Soon Shiong and an Associate presented three talks at the AUA this last	End2War	4	5/7/2024
495	Thanks, completely understood! It feels like the CEO has done this before and pu	zagnut1	1	5/7/2024
494	I was saying there are other possible explanations besides shorts being trapped.	ghettogoulash	-	5/7/2024
493	Gosh I hope not! I was referring to the last time at $2-3. You referred to it re	ghettogoulash	-	5/7/2024
492	Immunitybio Inc IBRX:NASDAQ ImmunityBio Completes GMP Drug Substance Manufactur	JJINV	3	5/7/2024
491	Not sure if I understand what you’re saying. Do you think the shorts can bring u	zagnut1	-	5/6/2024
490	The most logical and lucrative place to free up shares is at $2-3.	ghettogoulash	-	5/6/2024
489	Yes, they get margin calls. Concerning risk management, Charles Gradante, long t	ghettogoulash	-	5/6/2024
488	Thanks GG, the value of this board for this lazy buy and hold investor. 4x 170 g	TinfoilHat	3	5/5/2024
487	Short Interest as of Friday [graphic]	ghettogoulash	2	5/5/2024
486	Maybe you should x that by 4. Dosing in P2b is at weeks 0, 4, 8, and 52.	ghettogoulash	-	5/5/2024

Go to reply# or date (mm/dd/yy):